Last update June 9, 2018
Incompatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Phenindione is also known as
Phenindione in other languages or writings:
Phenindione belongs to this group or family:
Main tradenames from several countries containing Phenindione in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 100 | % |
Molecular weight | 222 | daltons |
Protein Binding | 88 | % |
Tmax | 1.3 | hours |
T½ | 5 - 6 | hours |
Theoretical Dose | 0.15 - 0.75 | mg/Kg/d |
Relative Dose | 12 - 60 | % |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by El Parto Es Nuestro of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
An anticoagulant derived from indandione. Vitamin K antagonist.
Administered orally.
Used less and less due to its serious side effects, which is why it has been withdrawn from sale in many countries (AAP 2001).
It is excreted in breastmilk in significant amounts (Goguel 1970).
There is a published a case of severe scrotal hematoma after surgical intervention (herniorrhaphy) in an infant whose mother was being treated with phenindione (Eckstein 1970).